Lisa Baddi DO in Chicago, Illinois

Home Illinois Chicago

Lisa Baddi DO has Hematology/oncology as her primary medical specialty. Their primary office is: 7447 W Talcott Ave in Chicago, Illinois.

They're a part of the: Illinois Cancer Specialists medical group which has around 31 members. You can call their office at 773-774-0042 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Midwestern University, Chicago College Of Osteopathic Med and graduated in 1998 (around 26 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Lisa L Baddi DO Office Phone and Directions

Lisa Baddi DO
Illinois Cancer Specialists
7447 W Talcott Ave
Chicago, Illinois 60631
773-774-0042

Patient Ratings
Please rate your experience with Lisa Baddi DO below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 773-774-0042

Enter a starting address:

Healthcare Info for Lisa Baddi DO

Medical School: Midwestern University, Chicago College Of Osteopathic Med
Graduation Year: 1998
The Primary Medical Specialty for Lisa Baddi DO is listed as: Hematology/oncology
Credentials: DO
Additional Credentials:
Approximate Years of Experience: 26
PAC (PECOS ID)#: 3274560206
NPI #: 1780683250
NPI Created On: 07/18/2005
NPI Last Updated Listed as: 12/17/2021
Primary Taxonomy Code: 207RH0003X
License Number:
036104349
Listed Gender: Female

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Hydration infusion into a vein 31 minutes to 1 hour
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
Application of on-body injector for injection under skin
Infusion of chemotherapy into a vein up to 1 hour
Infusion of chemotherapy into a vein
Infusion of different chemotherapy drug or substance into a vein up to 1 hour
Irrigation of implanted venous access drug delivery device
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 50 minutes per day
Subsequent hospital inpatient care, typically 15 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a
Injection, denosumab, 1 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788676009

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $65

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781008035

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781008039

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781008037

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781008041

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 793953783

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832181491

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: TUKYSA

Open Associated Drug #1: 51144-001-60

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832181523

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: TUKYSA

Open Associated Drug #1: 51144-001-60

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832181581

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: TUKYSA

Open Associated Drug #1: 51144-001-60

Payments Total: $12

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783721401

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: ABECMA

Open Associated Drug #1: 59572-515-01

Hematology/oncology Professionals in Chicago

1.
Ira Oliff MD

7435 W Talcott Ave
Chicago, IL
Presence Healthcare Services

2.
Ira Oliff MD

2800 N Sheridan Rd
Chicago, IL
Presence Healthcare Services

3.
Sami Atassi MD

2600 S Michigan Ave
Chicago, IL

4.
Sami Atassi MD

1901 W Harrison St
Chicago, IL
Cook County

5.
Sylvia Falls

9831 S Western Ave
Chicago, IL
Advocate Health And Hospitals Corporation

6.
Adam Duvall

5841 S Maryland Ave
Chicago, IL
The University Of Chicago Medical Center

Providers in Illinois Cancer Specialists

1.Zachary Andor

1710 N Randall Rd
Elgin Il 60123-9405
Illinois Cancer Specialists
Physician Assistant

2.Zachary Andor

8915 W Golf Rd
Niles Il 60714-5905
Illinois Cancer Specialists
Physician Assistant

3.Lisa Baddi Do

7447 W Talcott Ave
Chicago Il 60631-3712
Illinois Cancer Specialists
Hematology/oncology

4.Sonia Christian

8915 W Golf Rd
Niles Il 60714-5905
Illinois Cancer Specialists
Hematology/oncology

5.Bety Ciobanu

7447 W Talcott Ave
Chicago Il 60631-3712
Illinois Cancer Specialists
Internal Medicine

6.Bety Ciobanu

8915 W Golf Rd
Niles Il 60714-5905
Illinois Cancer Specialists
Internal Medicine

View all 31 members of Illinois Cancer Specialists medical group